Paper177449
A reconsideration of a thyroid-stimulating immunoglobulin as the cause of hyperthyroidism in Graves' disease.
McKenzie JM and 1 other. J Clin Endocrinol Metab, 1976. Cited by 131 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. A reconsideration of a thyroid-stimulating immunoglobulin as the cause of hyperthyroidism in Graves' disease. Papers, record 177449. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/177449
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A reconsideration of a thyroid-stimulating immunoglobulin as the cause of hyperthyroidism in Graves' disease.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Graves Disease | Major topic |
| Hyperthyroidism | Major topic |
| Immunoglobulins | Major topic |
| Thyroid Gland | Major topic |
| Animals | |
| Cyclic AMP | |
| Humans | |
| Immunoglobulin G | |
| Long-Acting Thyroid Stimulator | |
| Mice |
Source PubMed
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 131 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39,169,342 | Prognostic factors for thyroid-stimulating immunoglobulin normalization in moderate-to-severe Graves' orbitopathy: a 36-month longitudinal study. | BMC Ophthalmol | 2024 | https://conductscience.org/library/papers/39169342 | PubMed |
| 6,894,884 | Graves' hyperthyroidism and ophthalmopathy following treatment of spontaneous hypothyroidism with levothyroxine. | Can Med Assoc J | 1981 | https://conductscience.org/library/papers/6894884 | PubMed |
| 6,894,603 | The nude mouse. A possible experimental model for investigation of human thyroid tissue. | J Endocrinol Invest | 1981 | https://conductscience.org/library/papers/6894603 | PubMed |
| 6,801,107 | Familial inappropriate TSH secretion: evidence suggesting a dissociated pituitary resistance to T3 and T4. | J Endocrinol Invest | 1981 | https://conductscience.org/library/papers/6801107 | PubMed |
| 6,325,527 | Thyroid hormone secretion is more sensitive than thyroid cyclic AMP accumulation to stimulation with LATS in mice in vitro and in vivo. | J Endocrinol Invest | 1984 | https://conductscience.org/library/papers/6325527 | PubMed |
| 6,296,219 | Monoclonal antibodies to the thyrotropin receptor: the identification of blocking and stimulating antibodies. | J Endocrinol Invest | 1982 | https://conductscience.org/library/papers/6296219 | PubMed |
| 6,292,912 | Monoclonal antibodies to the thyrotropin receptor: stimulating and blocking antibodies derived from the lymphocytes of patients with Graves disease. | Proc Natl Acad Sci U S A | 1982 | https://conductscience.org/library/papers/6292912 | PubMed |
| 6,251,989 | Thyroid-stimulating antibody (TSab) detected in sera of Graves' patients using human thyroid cell cultures. | Clin Exp Immunol | 1980 | https://conductscience.org/library/papers/6251989 | PubMed |
| 6,147,408 | Thyroid stimulating immunoglobulins. The Watson Smith lecture 1983. | J R Coll Physicians Lond | 1984 | https://conductscience.org/library/papers/6147408 | PubMed |
| 6,147,216 | Effect of carbimazole treatment on specific and non-specific immunological parameters in patients with Graves' disease. | Clin Exp Immunol | 1984 | https://conductscience.org/library/papers/6147216 | PubMed |
| 6,138,363 | Immunoglobulin G inhibitor of thyroid-stimulating antibody is a cause of delay in the onset of neonatal Graves' disease. | J Clin Invest | 1983 | https://conductscience.org/library/papers/6138363 | PubMed |
| 6,132,943 | Effect of plasmapheresis and steroid treatment on thyrotropin binding inhibitory immunoglobulins in a patient with exophthalmos and a patient with pretibial myxedema. | J Endocrinol Invest | 1982 | https://conductscience.org/library/papers/6132943 | PubMed |
| 6,088,581 | Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins. | J Clin Invest | 1984 | https://conductscience.org/library/papers/6088581 | PubMed |
| 2,880,683 | Thyroid stimulating immunoglobulin (TSI) synthesis by pokeweed mitogen (PWM) stimulated peripheral blood lymphocytes (PBL) from Graves' disease (GD) patients. | Clin Exp Immunol | 1986 | https://conductscience.org/library/papers/2880683 | PubMed |
| 381,768 | [Cell receptor defects as the cause of endocrine and metabolic diseases (author's transl)]. | Klin Wochenschr | 1979 | https://conductscience.org/library/papers/381768 | PubMed |
| 90,689 | Determination of thyroid stimulating immunoglobulins (TSI) during the course of Graves' disease. A reliable indicator for remission and persistence of this disease? | J Endocrinol Invest | 1978 | https://conductscience.org/library/papers/90689 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/177449
GET https://conductscience.org/api/papers/v1/177449/authors